Results showed that IRs of MACE and MI per 100 person-years increased corresponding with the patient’s 10-year ASCVD risk score. 2,3 However, a substantially significant increase was seen among those ...

Elevated concentrations of lipoprotein(a) are not associated with adverse cardiovascular outcomes among patients with a recent acute coronary syndrome treated with statins, according to a new ...

Baseline lipoprotein a, or Lp(a), levels are strongly associated with major adverse cardiovascular events (MACE) in high-risk patients with elevated triglyceride levels receiving statin therapy, a new ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Major adverse CV events were predicted in patients with recent ACS based on their lipoprotein(a) ...

The risk for major adverse CV events after recent ACS could be predicted by baseline lipoprotein(a) and corrected LDL levels and their reductions with alirocumab, according to an analysis of the ...